Stock Forecast

  Materialise NV ( MTLS) Stock. Should you Buy or Sell?    $ 12.67

0.36 (2.76 %)

Materialise NV Analysis

Updated on 10-09-2022
Symbol MTLS
Price $12.67
Beta 0.716
Volume Avg. $183.99 thousand
Market Cap $748.33 M
52 Week Range $11.13 - $27.55

Materialise NV opened the day at $12.67 which is +'2.76 % on yesterday's close. Materialise NV has a 52 week high of $27.55 and 52 week low of $11.13, which is a difference of $16.42. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $748.33 M and total net profit is $205450000 which means the company is trading at 3.64 times profit to market capitalization. Theoretically, if you were to buy Materialise NV for $748.33 M, it would take 15 years to get your money back. Materialise NV are in the Software—Application space which will have a sweet spot and industry standard for net profit multiples.

Price Chart

1 D | All


Materialise NV Stock Forecast - Is Materialise NV a Buy or Sell?

DCF ScoreStrong Buy
ROE ScoreNeutral
ROA ScoreNeutral
DE ScoreBuy
PE ScoreStrong Buy
PB ScoreStrong Buy
Overall RecommendationStrong Buy

Growth and Value

PE Ratio 50.680
Dividend Yiel 0.000
Net Profit Margin 0.066

Valuing Materialise NV

Price Book Value Ratio 2.708 Price To Book Ratio 2.708
Price To Sales Ratio 2.888 Price Earnings Ratio 43.987

How liquid is Materialise NV

Current Ratio 2.269
Quick Ratio 2.057


Debt Ratio 0.440 Debt Equity Ratio 0.787
Long Term Debt To Capitalization 0.227 Total Debt To Capitalization 0.278

Latest news about Materialise NV

Materialise NV's (MTLS) CEO Fried Vancraen on Q2 2022 Results - Earnings Call Transcript

Materialise NV (NASDAQ:MTLS ) Q2 2022 Earnings Conference Call July 28, 2022 8:30 AM ET Company Participants Harriet Fried – Investor Relations-LHA Fried Vancraen – Founder and Chief Executive Officer Peter Leys – Executive Chairman Johan Albrecht – Chief Financial Officer Conference Call Participants Jason Celino – KeyBanc Noelle Dilts – Stifel Operator Good day. And thank you for standing by.

Date : 28/07/2022

Materialise (MTLS) Q2 Earnings Meet Estimates

Materialise (MTLS) delivered earnings and revenue surprises of 0% and 4.32%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Date : 28/07/2022

Materialise Could Be A Major Cathie Wood Selling Test

ARKK has started selling shares of the software company Materialise. Flagship ETF owns more than 7% of MTLS outstanding shares.

Date : 15/06/2022

Detoxify Your Holdings by Steering Clear of These 4 Stocks

Getting rid of fundamentally weak toxic stocks is important to shield your portfolio from losses. MSGE, MTLS, INNV and LGND are a few toxic stocks according to our model that you should dump now.

Date : 17/05/2022

Materialise NV (MTLS) CEO Wilfried Vancraen on Q1 2022 Results - Earnings Call Transcript

Materialise NV (NASDAQ:MTLS ) Q1 2022 Earnings Conference Call April 28, 2022 8:30 AM ET Company Participants Harriet Fried - IR Peter Leys - Executive Chairman Johan Albrecht - EVP & CFO Wilfried Vancraen - Founder, CEO & Director Conference Call Participants Jacob Stephan - Lake Street Capital Noelle Dilts - Stifel, Nicolaus & Company Gregory Ramirez - Bryan Garnier & Co Ltd Jason Celino - KeyBanc Capital Markets Operator Good day, and thank you for standing by. Welcome to the Q1 2022 Materialise Financial Results Conference Call.

Date : 28/04/2022

About Materialise NV

CEO : Mr. Wilfried Vancraen
Sector : Technology
Industry : Software—Application

Website :

Exchange : NASDAQ Global Select

Description :

Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. Its Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The company's Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. Its Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

My Newsletter

Sign Up For Updates & Newsletters